Fund
Invus
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 3
- Lead
- 0
- New entries
- 3
- Follow ons
- 0
- Latest operation
- 24 September 2026
- Sectors
- Medtech, Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 24 Sept | United States, Medtech | Series D and later | 250 M$ | Participant |
| 09 Sept | United States, Biotech | Series D and later | 275 M$ | Participant |
| 09 Sept | United States, Biotech | 50 M$ | Participant |
Co investors 26 funds crossed
- Ackman Oxman Institute 1 operation
- ARCH Venture Partners 1 operation
- ARK Invest 1 operation
- B Capital 1 operation
- Braidwell 1 operation
- BVF Partners 1 operation
- Duquesne Family Office 1 operation
- Eli Lilly and Company 1 operation
- Farallon Capital Management 1 operation
- GV 1 operation
- Hitachi Ventures 1 operation
- Illumina Ventures 1 operation
- Janus Henderson Investors 1 operation
- JDRF T1D Fund 1 operation
- JSL Health Capital 1 operation
- Korea Investment Partners 1 operation
- Kura Oncology 1 operation
- Matrix Capital Management 1 operation
- Mirae Asset Capital 1 operation
- Montanova 1 operation
- Mubadala Capital 1 operation
- Nolan Capital 1 operation
- Pershing Square 1 operation
- RTW Investments 1 operation
- SoftBank Vision Fund 2 1 operation
- Venrock 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.